Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-2-25
pubmed:abstractText
Galectin-3 (Gal-3) is a 26-kDa lectin known to regulate many aspects of inflammatory cell behavior. We assessed the hypothesis that increased levels of Gal-3 contribute to atherosclerotic plaque progression by enhancing monocyte chemoattraction through macrophage activation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1524-4636
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
433-40
pubmed:meshHeading
pubmed-meshheading:18096829-Animals, pubmed-meshheading:18096829-Biological Markers, pubmed-meshheading:18096829-Blotting, Western, pubmed-meshheading:18096829-Carotid Arteries, pubmed-meshheading:18096829-Carotid Stenosis, pubmed-meshheading:18096829-Cells, Cultured, pubmed-meshheading:18096829-Chemotaxis, pubmed-meshheading:18096829-Disease Models, Animal, pubmed-meshheading:18096829-Disease Progression, pubmed-meshheading:18096829-Galectin 3, pubmed-meshheading:18096829-Humans, pubmed-meshheading:18096829-Immunohistochemistry, pubmed-meshheading:18096829-Inflammation, pubmed-meshheading:18096829-Macrophage Activation, pubmed-meshheading:18096829-Macrophages, pubmed-meshheading:18096829-Mice, pubmed-meshheading:18096829-Mice, Inbred C57BL, pubmed-meshheading:18096829-Monocytes, pubmed-meshheading:18096829-RNA, pubmed-meshheading:18096829-Random Allocation, pubmed-meshheading:18096829-Sensitivity and Specificity, pubmed-meshheading:18096829-Up-Regulation
pubmed:year
2008
pubmed:articleTitle
Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction.
pubmed:affiliation
Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't